EMA Says Yes To GSK’s Omjjara, UCB’s Rystiggo and Novartis’ Spexotras

 
• By Eliza Slawther
  
3d render of Europe map Earth globe
Eight drugs are nearing the EU market
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Pink Sheet